Cargando…
Treatment of Transthyretin Amyloid Cardiomyopathy: The Current Options, the Future, and the Challenges
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressively debilitating, rare disease associated with high mortality. ATTR-CM occurs when TTR amyloid protein builds up in the myocardium along with different organs, most commonly the peripheral and the autonomic nervous systems. Managing the c...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031576/ https://www.ncbi.nlm.nih.gov/pubmed/35456241 http://dx.doi.org/10.3390/jcm11082148 |